Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-13

Clinical Trial Update: Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sildenafil for treatment of priapism in men with sickle cell disease has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Johns Hopkins University | Conditions: Sickle Cell Disease, Priapism | Phase 2 | Status: COMPLETED | Results posted: 2017-04-13